LISATA THERAPEUTICS, INC. Other Comprehensive Income, Other, Net of Tax
LISATA THERAPEUTICS, INC. (LSTA) reported Other Comprehensive Income, Other, Net of Tax of $0 for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeOtherNetOfTax · last filed 2012-11-13
- LISATA THERAPEUTICS, INC. other comprehensive income, other, net of tax for the quarter ending 2012-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. other comprehensive income, other, net of tax for the quarter ending 2012-06-30 was -$169.99K.
- LISATA THERAPEUTICS, INC. other comprehensive income, other, net of tax for the quarter ending 2012-03-31 was -$169.99K.
- LISATA THERAPEUTICS, INC. other comprehensive income, other, net of tax for the quarter ending 2011-09-30 was $0.00.
| Period end | Other Comprehensive Income, Other, Net of Tax 3 month | Other Comprehensive Income, Other, Net of Tax 6 month | Other Comprehensive Income, Other, Net of Tax 9 month |
|---|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 | -$169.99K derived: sum of 2 quarters · filed 2012-11-13 | -$169.99K 10-Q · filed 2012-11-13 |
| 2012-06-30 | -$169.99K 10-Q · filed 2012-08-14 | -$169.99K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$169.99K 10-Q · filed 2012-05-11 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |